Health Care

2531 posts
Quantum computer

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal

Cybersecurity stock Quantum eMotion (TSXV:QNC) takes a major step in the go-to-market strategy for its Sentry-Q platform.
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
AI generated stock image

Investing in Canadian medical stocks under $10

Healthcare stocks in Canada are publicly traded companies that operate in various sectors of the healthcare industry.

A potential breakthrough in spinal cord and optic nerve injury treatment

A potential breakthrough in spinal cord and optic nerve injury treatment
  • Research
  • 1 min
  • 19 December 2024 07:01 (EST)
AI generated stock image

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities.

Quipt boosts revenue and customers in Q4

Quipt Home Medical (TSX:QIPT) reported its financial results for Q4 and fiscal year ended September 30, 2024
Image via Cloud DX

Cloud DX sells subsidiary, completes first stage of restructuring

Cloud DX (TSXV:CDX) reported the sale of its wholly owned subsidiary, Cloud Diagnostics Canada ULC to 1493907 B.C. Ltd.
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
Image of a brain via Alpha Cognition

Alpha Cognition sees promising data for military-related trauma treatment

Alpha Cognition (CSE:ACOG) announced preclinical data to support continued development of ALPHA-1062 to treat mild traumatic brain injury.
The nervous system

NurExone Biologic announces important test results

NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing its ExoPTEN to treat patients with acute spinal cord injuries.
  • Research
  • 4 mins
  • 11 December 2024 06:59 (EST)
AI medicine

Micro-cap AI stock inks deal with top pharma company

NetraMark (CSE:AIAI), a micro-cap AI stock optimizing clinical trials, signs a pilot agreement with a top-five pharmaceutical company.
Promino Nutritional Sciences product

Here’s why dozens of pro athletes are paying attention to this product

Promino Nutritional Sciences (CSE:MUSL) is at the forefront of the market for nutritional supplements supporting muscle health.
Safe Supply Streaming logo against a landscape backdrop

Safe Supply Streaming to sell iodine tablets through Greenlane

Safe Supply Streaming (CSE:SPLY) portfolio company, Safety Strips Tech, collaborates with Greenlane to distribute Toxi Shield iodine tablets.
  • Research
  • 2 mins
  • 06 December 2024 14:43 (EST)
Lab work at Theratechnologies

Theratechnologies expands rare disease portfolio with Ionis partnership

Theratechnologies gains exclusive rights to two investigational RNA-targeted medicines from Ionis Pharmaceuticals, olezarsen and donidalorsen.
  • Research
  • 2 mins
  • 04 December 2024 13:25 (EST)
An AI generated photo of a stethoscope on a computerized setting

How one company is disrupting PoC testing

When it comes to Gemina Laboratories Ltd. (CSE:GLAB), the Canada and U.K.-based company is progressing a range of PoC diagnostic technologies.
Frequency Exchange's NIKKI wellness device

Boston Bruins president Cam Neely joins Frequency Exchange

Frequency Exchange (TSXV:FREQ), a health technology stock, appoints Boston Bruins president Cam Neely to its advisory board.